Daniel L. Flynn,Michael D. Kaufman,Brian D. Smith,Marc Rudoltz
申请号：
US15253279
公开号：
US20170209428A1
申请日:
2016.08.31
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to methods of inhibiting TIE2 kinase useful in the treatment of tumor growth, invasiveness, intravasation, dissemination, metastasis, and immunosuppression. Specifically, the invention relates to methods of using 1-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea and salts thereof of Formula I.
